Protara Therapeutics, Inc
Protara Therapeutics, Inc. is a biotechnology company based in New York, dedicated to advancing transformative therapies for serious diseases. Its lead investigational cell therapy, TARA-002, aims to treat non-muscle invasive bladder cancer and lymphatic malformations, benefiting from Rare Pediatric Disease Designation from the FDA.
In addition to TARA-002, Protara is developing IV Choline Chloride, a phospholipid substrate replacement therapy targeting patients on parenteral support, addressing the significant choline deficiency prevalent in this population. The company is committed to innovative treatments that cater to unmet medical needs in the oncology and pediatric spaces.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.